Jon R. Levine - 07 Nov 2025 Form 4 Insider Report for MARIMED INC. (MRMD)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jon R. Levine
Issuer symbol
MRMD
Transactions as of
07 Nov 2025
Transactions value $
-$2,135
Form type
4
Filing time
12 Nov 2025, 16:21:02 UTC
Previous filing
28 Oct 2025
Next filing
02 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Levine Jon R President and CEO, Director, 10%+ Owner C/O MARIMED INC., 10 OCEANA WAY, NORWOOD, /s/ Jon R. Levine 11 Nov 2025 0001789645

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRMD Common stock Options Exercise $0 +75K +0.36% $0.00 21M 07 Nov 2025 Direct F1
transaction MRMD Common stock Tax liability -$2.14K -22K -0.1% $0.10 21M 07 Nov 2025 Direct F2
holding MRMD Common stock 6.68M 07 Nov 2025 By the Jon Levine Family Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRMD Restricted Stock Units (RSU) Options Exercise $0 -75K -33.33% $0.00 150K 07 Nov 2025 Common Stock, par value $.001 per share 75K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs convert to shares of common stock on a one-for-one basis.
F2 Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
F3 These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 These RSUs were granted on November 7, 2023; the remaining RSUs will vest in two equal installments, on each of May 7, 2026 and November 7, 2026, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.